CATALIO CAPITAL MANAGEMENT, LP
CATALIO CAPITAL MANAGEMENT, LP is a Pre-seed, Seed, Series A, Series B, Series C+, buyout, debt and other fund in the US and London investing in Healthcare, biomedical-tech, drugs, devices, diagnostics, data, tools, healthcare-services and mental-health.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, buyout, debt, other
- Sectors
- Healthcare, biomedical-tech, drugs, devices, diagnostics, data, tools, healthcare-services, mental-health
- Invests in
- US-wide, London
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $2B
- Website
- cataliocapital.com
Check size not disclosed
Thesis
Catalio Capital Management, LP, founded in 2020, is a multi-strategy investment firm with approximately $2 billion in AUM as of October 2025. Headquartered in New York, NY, with offices in Baltimore, MD, and London, the firm focuses on the healthcare and biomedical technology sectors. Their investment thesis centers on identifying and supporting breakthrough biomedical technologies, including next-generation drugs, devices, diagnostics, data, tools, and healthcare services. Catalio invests across private, public, and credit markets, utilizing strategies such as private equity, structured opportunities, public equities, and co-investments. The firm leverages a network of world-renowned scientist-entrepreneurs as Venture Partners for proprietary deal flow and due diligence.
Common questions
Does CATALIO CAPITAL MANAGEMENT, LP invest at the Pre-seed stage?
Yes. CATALIO CAPITAL MANAGEMENT, LP lists Pre-seed, Seed, Series A, Series B, Series C+, buyout, debt and other among the stages it invests in.
Where does CATALIO CAPITAL MANAGEMENT, LP invest?
CATALIO CAPITAL MANAGEMENT, LP invests in the US and London.